Addex Therapeutics ADXN
NASDAQ ADXN
$2.96 +0.22 (+8.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Addex Therapeutics (ADXN) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Addex Therapeutics' Return on Capital Employed [ROCE] came in at -93.18% for Q2 2026, down 33.08 percentage points from -60.10% a year earlier and down 31.94 percentage points from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Addex Therapeutics' Return on Capital Employed [ROCE] was -41.19%, down 0.90 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +15.61 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -40.29% in FY2024 (+28.93 pp), -69.22% in FY2023 (+14.21 pp), -83.43% in FY2022 (+5.54 pp) and -88.97% in FY2021 (-32.17 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of +120.66 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 604.45 percentage points), and the weakest in Q1 2023 (a drop of 513.61 percentage points).
  • Business Quant data shows ADXN's Return on Capital Employed [ROCE] at -61.24% (Q1 2026), -48.20% (Q4 2025) and -67.57% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Addex Therapeutics 3.65 Mn -3.31 Mn - -95.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -95.18%
Mar 31, 2026 -61.16%
Dec 31, 2025 -47.94%
Sep 30, 2025 -34.77%
Jun 30, 2025 -30.06%
Mar 31, 2025 -28.68%
Dec 31, 2024 -25.48%
Sep 30, 2024 -24.91%
Jun 30, 2024 -42.36%
Mar 31, 2024 -593.07%
Dec 31, 2023 -183.12%
Sep 30, 2023 -406.18%
Jun 30, 2023 -482.45%
Mar 31, 2023 -668.71%
Dec 31, 2022 -544.03%
Sep 30, 2022 -433.77%
Jun 30, 2022 -310.81%
Mar 31, 2022 -181.11%
Dec 31, 2021 -166.72%
Sep 30, 2021 -144.84%
API Access

Addex Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ADXN&period=max&api_key=YOUR_API_KEY